Geron Corporation (www.geron.com) and the University of Edinburgh ( www.ed.ac.uk) announced today that they have entered into a collaboration to conduct preclinical safety and efficacy studies with three cell types derived from human embryonic stem cells (hESCs).

The cell types are hepatocytes for the treatment of liver failure and osteoblasts and chondrocytes for the treatment of musculoskeletal disorders, including osteoarthritis, bone fractures and osteoporosis. The studies, based at the University’s Centre for Regenerative Medicine, will be under the direction of Professor John Iredale, Dr. Phil Newsome, Dr. Brendon Noble and Professor Hamish Simpson.

Link


  • Edinburgh Confirmed Stem Cell Centre Plan
  • Vets from India and Japan plans to prolong animal lives through stem cell technology
  • FDA To Design Blueprint For Human Experiment With Human Embryonic Stem Cells
  • £2Million Stem Cell Research Centre at Scotland
  • Stem Cells Could Help Growing Insulin Preducing Cells
  • British Heart Foundation Granted £240,000 for Stem Cell Research to Edinburgh University
  • Stem Cell Breakthrough: New Stem Cells from Clinically Unusable Human Egg
  • Neural Stem Cells Established from Adult Brain
  • Embryonic Stem Cell Therapy is Harmless for Acute Spinal Cord Injury Treatment
  • Obama victory a hope for stem cell stem cell reserach firms